JP2022507795A5 - - Google Patents

Info

Publication number
JP2022507795A5
JP2022507795A5 JP2021527866A JP2021527866A JP2022507795A5 JP 2022507795 A5 JP2022507795 A5 JP 2022507795A5 JP 2021527866 A JP2021527866 A JP 2021527866A JP 2021527866 A JP2021527866 A JP 2021527866A JP 2022507795 A5 JP2022507795 A5 JP 2022507795A5
Authority
JP
Japan
Prior art keywords
optionally substituted
group
alkyl
alkylene
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021527866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022507795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062045 external-priority patent/WO2020106636A1/en
Publication of JP2022507795A publication Critical patent/JP2022507795A/ja
Publication of JP2022507795A5 publication Critical patent/JP2022507795A5/ja
Pending legal-status Critical Current

Links

JP2021527866A 2018-11-19 2019-11-18 C10環状置換13員マクロライド及びそれらの使用 Pending JP2022507795A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769413P 2018-11-19 2018-11-19
US62/769,413 2018-11-19
PCT/US2019/062045 WO2020106636A1 (en) 2018-11-19 2019-11-18 C11-cyclic substituted 13-membered macrolides and uses thereof

Publications (2)

Publication Number Publication Date
JP2022507795A JP2022507795A (ja) 2022-01-18
JP2022507795A5 true JP2022507795A5 (cg-RX-API-DMAC10.html) 2022-11-29

Family

ID=68965978

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527866A Pending JP2022507795A (ja) 2018-11-19 2019-11-18 C10環状置換13員マクロライド及びそれらの使用

Country Status (12)

Country Link
US (1) US20220177508A1 (cg-RX-API-DMAC10.html)
EP (1) EP3883945A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022507795A (cg-RX-API-DMAC10.html)
KR (1) KR20210123288A (cg-RX-API-DMAC10.html)
CN (1) CN113646319A (cg-RX-API-DMAC10.html)
AU (2) AU2019385383B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009607A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120235A1 (cg-RX-API-DMAC10.html)
IL (2) IL283185B2 (cg-RX-API-DMAC10.html)
MX (1) MX2021005421A (cg-RX-API-DMAC10.html)
SG (1) SG11202105228SA (cg-RX-API-DMAC10.html)
WO (1) WO2020106636A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023235380A1 (en) * 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
KR20250048331A (ko) * 2022-08-11 2025-04-08 지카니 테라퓨틱스, 인크. 치료용 아자케톨라이드 제조용 합성 공정 및 중간체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
ATE243703T1 (de) * 2000-01-27 2003-07-15 Pfizer Prod Inc Antibiotische azalid-zusammensetzungen
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. 10a-アザライド化合物
EP2588084B1 (en) * 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
EP4095146A1 (en) * 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) * 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) * 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Similar Documents

Publication Publication Date Title
DK2997011T3 (en) SULFAMOYLPYRROLAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES TO TREAT HEPATITIS B
JP2021534124A5 (cg-RX-API-DMAC10.html)
AU2017382405A1 (en) Compositions and methods for inhibiting arginase activity
DK3024819T3 (en) GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
HRP20120066T1 (hr) Kalijeva sol inhibitora hiv integraze
JP2010523522A5 (cg-RX-API-DMAC10.html)
JP2017537158A5 (cg-RX-API-DMAC10.html)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
JP2017537949A5 (cg-RX-API-DMAC10.html)
JP2015514063A5 (cg-RX-API-DMAC10.html)
JP2020507589A5 (cg-RX-API-DMAC10.html)
JP2011506566A5 (cg-RX-API-DMAC10.html)
JP2013544276A5 (cg-RX-API-DMAC10.html)
EA200970535A1 (ru) Антибактериальные производные хинолина
KR102519536B1 (ko) 트리시클릭 회전장애이성질체 화합물
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
AR064318A1 (es) Compuesto y composicion derivada de aril sulfamida, uso del compuesto y proceso para la preparacion del compuesto
EA200970534A1 (ru) Антибактериальные производные хинолина
JP2013515037A5 (cg-RX-API-DMAC10.html)
JP2004525183A5 (cg-RX-API-DMAC10.html)
CA2463544A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
CY1111744T1 (el) Τροποποιητες της δραστηριοτητας toy υποδοχεα χημειοκινων, κρυσταλλικες μορφες και διεργασια
TW202130635A (zh) 新穎取代縮環型化合物
JP2022507776A5 (cg-RX-API-DMAC10.html)
JP2017535566A5 (cg-RX-API-DMAC10.html)